The Significance of Natural Product Derivatives and Traditional Medicine for COVID-19
出版年份 2020 全文链接
标题
The Significance of Natural Product Derivatives and Traditional Medicine for COVID-19
作者
关键词
-
出版物
Processes
Volume 8, Issue 8, Pages 937
出版商
MDPI AG
发表日期
2020-08-04
DOI
10.3390/pr8080937
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs
- (2020) Hui Luo et al. Chinese Journal of Integrative Medicine
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
- (2020) Roujian Lu et al. LANCET
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Traditional Chinese Medicine for COVID-19 Treatment
- (2020) Jun-ling Ren et al. PHARMACOLOGICAL RESEARCH
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
- (2020) Daniel Wrapp et al. SCIENCE
- SR-BI as a target of natural products and its significance in cancer
- (2020) Dongdong Wang et al. SEMINARS IN CANCER BIOLOGY
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Is traditional Chinese medicine useful in the treatment of COVID-19?
- (2020) Kai Zhang AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Ivermectin and Novel Coronavirus Disease (COVID-19): Keeping Rigor in Times of Urgency
- (2020) Carlos Chaccour et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Of chloroquine and COVID-19
- (2020) Franck Touret et al. ANTIVIRAL RESEARCH
- The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
- (2020) Steven P. Treon et al. BLOOD
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing
- (2020) Maria Garcia‐Cremades et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID‐19
- (2020) Bharat Damle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
- (2020) Waleed Alhazzani et al. CRITICAL CARE MEDICINE
- Teicoplanin: an alternative drug for the treatment of COVID-19?
- (2020) Sophie Alexandra Baron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A Review of SARS-CoV-2 and the Ongoing Clinical Trials
- (2020) Yung-Fang Tu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
- (2020) James M. Sanders et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
- (2020) Calvin J. Gordon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
- (2020) Zhen Zhu et al. JOURNAL OF INFECTION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Potential therapeutic agents against COVID-19
- (2020) Chih-Chia Lu et al. Journal of the Chinese Medical Association
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Endocrine and metabolic link to coronavirus infection
- (2020) Stefan R. Bornstein et al. Nature Reviews Endocrinology
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient
- (2020) Emily Hillaker et al. PHARMACOTHERAPY
- Phylogenetic network analysis of SARS-CoV-2 genomes
- (2020) Peter Forster et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)
- (2020) Ruiyun Li et al. SCIENCE
- An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
- (2020) Timothy P. Sheahan et al. Science Translational Medicine
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
- (2020) Philippe Gautret et al. Travel Medicine and Infectious Disease
- Combination of western medicine and Chinese traditional patent medicine in treating a family case of COVID-19
- (2020) Li Ni et al. Frontiers of Medicine
- Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
- (2020) Xiaoyan Liu et al. Acta Pharmaceutica Sinica B
- Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19
- (2020) Jiansheng Huang et al. Journal of Clinical Medicine
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- (2020) Ka-Tim Choy et al. ANTIVIRAL RESEARCH
- Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends
- (2020) George Cherry et al. Expert Review of Anti-Infective Therapy
- COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis
- (2020) Alessandra Fierabracci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identifying potential treatments of COVID-19 from Traditional Chinese Medicine (TCM) by using a data-driven approach
- (2020) Xia Ren et al. JOURNAL OF ETHNOPHARMACOLOGY
- Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2
- (2020) Brandi N. Williamson et al. NATURE
- Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
- (2020) Li Runfeng et al. PHARMACOLOGICAL RESEARCH
- Highlights of traditional Chinese medicine frontline expert advice in the China national guideline for COVID-19
- (2020) Leonard T.F. Ho et al. European Journal of Integrative Medicine
- Prevalence of Taste and Smell Dysfunction in Coronavirus Disease 2019
- (2020) Giuseppe Mercante et al. JAMA Otolaryngology-Head & Neck Surgery
- Guideline-Based Chinese Herbal Medicine Treatment Plus Standard Care for Severe Coronavirus Disease 2019 (G-CHAMPS): Evidence From China
- (2020) Yong-an Ye et al. Frontiers in Medicine
- Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines
- (2020) Lin Ang et al. Integrative Medicine Research
- Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
- (2020) Tarek Mohamed Abd El-Aziz et al. INFECTION GENETICS AND EVOLUTION
- The ethnopharmacological literature: An analysis of the scientific landscape
- (2019) Andy Wai Kan Yeung et al. JOURNAL OF ETHNOPHARMACOLOGY
- Impact of natural products on the cholesterol transporter ABCA1
- (2019) Dongdong Wang et al. JOURNAL OF ETHNOPHARMACOLOGY
- A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
- (2019) Sabue Mulangu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review
- (2018) Domenico Plantone et al. CLINICAL DRUG INVESTIGATION
- The arrival of predictive biomarkers for monitoring therapy response to natural compounds in cancer drug discovery
- (2018) Khalid El Bairi et al. BIOMEDICINE & PHARMACOTHERAPY
- Drug repurposing: progress, challenges and recommendations
- (2018) Sudeep Pushpakom et al. NATURE REVIEWS DRUG DISCOVERY
- Ivermectin to reduce malaria transmission I. Pharmacokinetic and pharmacodynamic considerations regarding efficacy and safety
- (2017) Carlos Chaccour et al. MALARIA JOURNAL
- Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders
- (2016) Birgit Waltenberger et al. MOLECULES
- Coronaviruses — drug discovery and therapeutic options
- (2016) Alimuddin Zumla et al. NATURE REVIEWS DRUG DISCOVERY
- Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
- (2016) Michael F. Marmor et al. OPHTHALMOLOGY
- Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
- (2016) Jean-François Rossignol Journal of Infection and Public Health
- Discovery and resupply of pharmacologically active plant-derived natural products: A review
- (2015) Atanas G. Atanasov et al. BIOTECHNOLOGY ADVANCES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started